Search

Displaying results 6241 - 6250 of 8196 in total
  1. Drug

    NNZ-2591

    go.drugbank.com/drugs/DB15601
    Investigational

    NNZ-2591 (cyclo-L-glycyl-L-2-allylproline)[A189390] is an investigational synthetic analog of cyclic glycine-proline (cGP), a breakdown product of human insulin-like growth factor 1 (IGF-1), that has been

  2. Drug

    Omberacetam

    go.drugbank.com/drugs/DB19956
    Experimental

    Omberacetam has a monoisotopic molecular weight of 318.16 Da.

  3. Drug

    Vibozilimod

    go.drugbank.com/drugs/DB21505
    Experimental

    Vibozilimod has a monoisotopic molecular weight of 541.23 Da.

  4. Drug

    Zectivimod

    go.drugbank.com/drugs/DB21525
    Experimental

    Zectivimod has a monoisotopic molecular weight of 527.17 Da.

  5. Drug

    Vormatrigine

    go.drugbank.com/drugs/DB21731
    Investigational

    Vormatrigine has a monoisotopic molecular weight of 406.09 Da.

  6. Drug

    Fidexaban

    go.drugbank.com/drugs/DB19562
    Experimental

    Fidexaban has a monoisotopic molecular weight of 526.18 Da.

  7. Drug

    Lanepitant

    go.drugbank.com/drugs/DB19599
    Experimental

    The usage of the INN stem '-pitant' in the name indicates that Lanepitant is a neurokinin NK1​ (substance P) receptor antagonist. Lanepitant has a monoisotopic molecular weight of 559.35 Da.

  8. Drug

    Elziverine

    go.drugbank.com/drugs/DB19624
    Experimental

    Elziverine has a monoisotopic molecular weight of 543.27 Da.

  9. Drug

    Dexsecoverine

    go.drugbank.com/drugs/DB19837
    Experimental

    Dexsecoverine has a monoisotopic molecular weight of 345.27 Da.

  10. Drug

    Tefazoline

    go.drugbank.com/drugs/DB20397
    Experimental

    Tefazoline has a monoisotopic molecular weight of 214.15 Da.